• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白 90 抑制剂通过 PUMA 和 Bax 促进 p53 依赖性细胞凋亡。

Hsp90 inhibitors promote p53-dependent apoptosis through PUMA and Bax.

机构信息

Department of Pathology, University of Pittsburgh School of Medicine, 5117 Centre Ave., Pittsburgh, PA 15213, USA.

University of Pittsburgh Cancer Institute 5117 Centre Ave., Pittsburgh, PA 15213, USA.

出版信息

Mol Cancer Ther. 2013 Nov;12(11):2559-68. doi: 10.1158/1535-7163.MCT-13-0284. Epub 2013 Aug 21.

DOI:10.1158/1535-7163.MCT-13-0284
PMID:23966620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3823684/
Abstract

Hsp90 is widely overexpressed in cancer cells and believed to be essential for the maintenance of malignant phenotypes. Targeting Hsp90 by small molecules has shown promise in solid and hematologic malignancies, which likely involves degradation of client oncoproteins in a cell-type-specific manner. In this study, we found that structurally unrelated Hsp90 inhibitors induce DNA damage and apoptosis via p53-dependent induction of PUMA, which indirectly triggers Bax activation and mitochondrial dysfunction in colon cancer cells. Deficiency in PUMA, BAX, or p53, at lesser extent, abrogated 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced apoptosis and mitochondrial dysfunction, and enhanced clonogenic cell survival. Furthermore, suppression of p53-dependent p21 induction or enhanced p53 activation synergized with 17-AAG to induce PUMA-dependent apoptosis. Finally, PUMA was found to mediate apoptotic and therapeutic responses to the 17-AAG analog 17-DMAG in xenografts. These results show an important role of the p53/PUMA/Bax axis in Hsp90 inhibitor-induced killing of p53 wild-type cells, and have important implications for their clinical applications.

摘要

热休克蛋白 90(Hsp90)在癌细胞中广泛过表达,被认为是维持恶性表型所必需的。小分子靶向 Hsp90 在实体瘤和血液恶性肿瘤中显示出前景,这可能涉及以细胞类型特异性的方式降解客户癌蛋白。在这项研究中,我们发现结构上不相关的 Hsp90 抑制剂通过 p53 依赖性诱导 PUMA 诱导 DNA 损伤和细胞凋亡,这间接触发了结肠癌细胞中 Bax 的激活和线粒体功能障碍。在较小程度上,PUMA、BAX 或 p53 的缺乏会消除 17- 烯丙基-17-去甲氧基格尔德霉素(17-AAG)诱导的细胞凋亡和线粒体功能障碍,并增强集落形成细胞的存活。此外,抑制 p53 依赖性 p21 诱导或增强 p53 激活与 17-AAG 协同作用诱导依赖于 PUMA 的细胞凋亡。最后,发现 PUMA 介导了对 17-AAG 类似物 17-DMAG 的异种移植物中的凋亡和治疗反应。这些结果表明,p53/PUMA/Bax 轴在 Hsp90 抑制剂诱导的 p53 野生型细胞杀伤中起重要作用,这对其临床应用具有重要意义。

相似文献

1
Hsp90 inhibitors promote p53-dependent apoptosis through PUMA and Bax.热休克蛋白 90 抑制剂通过 PUMA 和 Bax 促进 p53 依赖性细胞凋亡。
Mol Cancer Ther. 2013 Nov;12(11):2559-68. doi: 10.1158/1535-7163.MCT-13-0284. Epub 2013 Aug 21.
2
Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors.17AAG 通过阻断 Hsp90 拮抗 MDMX 并与 Nutlin 协同作用诱导实体瘤中 p53 介导的细胞凋亡。
Cell Death Dis. 2011 May 12;2(5):e156. doi: 10.1038/cddis.2011.39.
3
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX.热休克蛋白90(HSP90)抑制剂17-AAG(坦螺旋霉素)诱导的细胞死亡模式取决于促凋亡蛋白BAX的表达。
Oncotarget. 2013 Nov;4(11):1963-75. doi: 10.18632/oncotarget.1419.
4
Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.通过 17-DMAG 抑制 Hsp90 以依赖 p53 的方式诱导细胞凋亡,从而预防成神经管细胞瘤。
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17037-42. doi: 10.1073/pnas.0902880106. Epub 2009 Sep 23.
5
Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA-dependent apoptosis in colorectal cancer.纯化的牡荆素化合物 1,一种新的分离得到的 neolignan 化合物,可促进结直肠癌细胞中依赖 PUMA 的细胞凋亡。
Cancer Med. 2018 Dec;7(12):6158-6169. doi: 10.1002/cam4.1769. Epub 2018 Nov 6.
6
Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.系统遗传剖析 p14ARF 介导的线粒体细胞死亡信号转导揭示了 p21CDKN1 和 BH3 仅蛋白 Puma/bbc3 的关键作用。
J Mol Med (Berl). 2010 Jun;88(6):609-22. doi: 10.1007/s00109-010-0606-5. Epub 2010 Apr 25.
7
HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio.热休克蛋白90抑制剂通过提高BAX/BCL-2比值增强塞来昔布对HT-29结肠癌细胞的抗增殖和凋亡作用。
Cell Mol Biol (Noisy-le-grand). 2016 Oct 31;62(12):62-67. doi: 10.14715/cmb/2016.62.12.11.
8
Inhibition of HSP90 by AUY922 Preferentially Kills Mutant KRAS Colon Cancer Cells by Activating Bim through ER Stress.AUY922对热休克蛋白90的抑制作用通过内质网应激激活Bim,优先杀死突变型KRAS结肠癌细胞。
Mol Cancer Ther. 2016 Mar;15(3):448-59. doi: 10.1158/1535-7163.MCT-15-0778. Epub 2016 Feb 1.
9
P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines.热休克蛋白90抑制剂17-烯丙基氨基-17-去甲氧基格尔德霉素对人口腔鳞状细胞癌细胞系的p53依赖性放射增敏作用
Int J Oncol. 2006 Nov;29(5):1111-7. doi: 10.3892/ijo.29.5.1111.
10
Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway.JKA97的抗癌作用与其通过Bax依赖且p53非依赖的途径诱导细胞凋亡有关。
J Biol Chem. 2008 Mar 28;283(13):8624-33. doi: 10.1074/jbc.M707860200. Epub 2008 Jan 23.

引用本文的文献

1
Deferential nephrotoxicity effect of lanthanum oxide nanoparticle responses to concentration and time in vivo.氧化镧纳米颗粒在体内对浓度和时间的差异性肾毒性作用。
Sci Rep. 2025 Jun 6;15(1):19926. doi: 10.1038/s41598-025-04996-0.
2
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer.靶向突变型KRAS结直肠癌中Myc驱动的应激易感性。
Mol Biomed. 2022 Mar 21;3(1):10. doi: 10.1186/s43556-022-00070-7.
3
Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes.p53 功能的调节通过形成非核异源蛋白复合物。
Biomolecules. 2022 Feb 18;12(2):327. doi: 10.3390/biom12020327.
4
Heat shock proteins-driven stress granule dynamics: yet another avenue for cell survival.热休克蛋白驱动的应激颗粒动态变化:细胞存活的又一途径。
Apoptosis. 2021 Aug;26(7-8):371-384. doi: 10.1007/s10495-021-01678-w. Epub 2021 May 12.
5
Fibroblast Senescence in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中的成纤维细胞衰老
Front Cell Dev Biol. 2020 Nov 25;8:593283. doi: 10.3389/fcell.2020.593283. eCollection 2020.
6
eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis.eIF4E S209 磷酸化使 myc 和应激驱动的肿瘤发生获得许可。
Elife. 2020 Nov 2;9:e60151. doi: 10.7554/eLife.60151.
7
Immunogenic cell death in colon cancer prevention and therapy.免疫原性细胞死亡在结直肠癌预防和治疗中的作用。
Mol Carcinog. 2020 Jul;59(7):783-793. doi: 10.1002/mc.23183. Epub 2020 Mar 25.
8
Gilteritinib induces PUMA-dependent apoptotic cell death via AKT/GSK-3β/NF-κB pathway in colorectal cancer cells.吉特替尼通过 AKT/GSK-3β/NF-κB 通路诱导结直肠癌细胞中 PUMA 依赖性细胞凋亡。
J Cell Mol Med. 2020 Feb;24(3):2308-2318. doi: 10.1111/jcmm.14913. Epub 2019 Dec 27.
9
HEATR1 modulates cell survival in non-small cell lung cancer via activation of the p53/PUMA signaling pathway.HEATR1通过激活p53/PUMA信号通路调节非小细胞肺癌中的细胞存活。
Onco Targets Ther. 2019 May 21;12:4001-4011. doi: 10.2147/OTT.S195826. eCollection 2019.
10
Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA-dependent apoptosis in colorectal cancer.纯化的牡荆素化合物 1,一种新的分离得到的 neolignan 化合物,可促进结直肠癌细胞中依赖 PUMA 的细胞凋亡。
Cancer Med. 2018 Dec;7(12):6158-6169. doi: 10.1002/cam4.1769. Epub 2018 Nov 6.

本文引用的文献

1
Crizotinib induces PUMA-dependent apoptosis in colon cancer cells.克唑替尼诱导结肠癌细胞中 PUMA 依赖性凋亡。
Mol Cancer Ther. 2013 May;12(5):777-86. doi: 10.1158/1535-7163.MCT-12-1146. Epub 2013 Feb 20.
2
Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation.靶向 Bax 相互作用位点揭示了只有同型寡聚化位点对其激活是必不可少的。
Cell Death Differ. 2013 May;20(5):744-54. doi: 10.1038/cdd.2013.4. Epub 2013 Feb 8.
3
The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.多靶点激酶抑制剂舒尼替尼通过 PUMA 诱导结肠癌细胞凋亡。
PLoS One. 2012;7(8):e43158. doi: 10.1371/journal.pone.0043158. Epub 2012 Aug 17.
4
Hsp90 molecular chaperone inhibitors: are we there yet?热休克蛋白 90 分子伴侣抑制剂:我们成功了吗?
Clin Cancer Res. 2012 Jan 1;18(1):64-76. doi: 10.1158/1078-0432.CCR-11-1000.
5
Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.热休克蛋白 90 抑制剂与癌症耐药性:联合应用热休克蛋白 90 抑制剂和其他抗癌药物的潜在治疗益处。
Biochem Pharmacol. 2012 Apr 15;83(8):995-1004. doi: 10.1016/j.bcp.2011.11.011. Epub 2011 Nov 22.
6
Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors.17AAG 通过阻断 Hsp90 拮抗 MDMX 并与 Nutlin 协同作用诱导实体瘤中 p53 介导的细胞凋亡。
Cell Death Dis. 2011 May 12;2(5):e156. doi: 10.1038/cddis.2011.39.
7
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab.HSP90 抑制在乳腺癌中有效:替吡法尼(17-AAG)联合曲妥珠单抗治疗曲妥珠单抗进展的 HER2 阳性转移性乳腺癌的 II 期试验。
Clin Cancer Res. 2011 Aug 1;17(15):5132-9. doi: 10.1158/1078-0432.CCR-11-0072. Epub 2011 May 10.
8
Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.热休克蛋白 90 通过功能性失活内源性 MDM2 和 CHIP 引起人癌细胞中突变型 p53 的异常稳定。
Mol Cancer Res. 2011 May;9(5):577-88. doi: 10.1158/1541-7786.MCR-10-0534. Epub 2011 Apr 8.
9
Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21.通过 PUMA 和 p21 解偶联辐射诱导的肠道损伤中的 p53 功能。
Mol Cancer Res. 2011 May;9(5):616-25. doi: 10.1158/1541-7786.MCR-11-0052. Epub 2011 Mar 30.
10
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.